urinary tract infectionsresistancevirulenceOne of the most frequent chronic complications occurred in diabetes patients are the urinary tract infections (UTIs). This study aimed to investigate the incidence of UTIs in a cohort of 93 (47 males: 46 females) diabetic patients, the prevalence of ...
Genito-urinary tract infections (GUTI) are the most common adverse event (AE) during therapy with sodium-glucose cotransporter 2 inhibitors (SGLT2i). We ev... GP Fadini,BM Bonora,M Sarangdhar,... - 《Diabetes Obesity & Metabolism》 被引量: 0发表: 2017年 加载更多来源...
Type 2 diabetes is a condition of blood sugar dysregulation. In general blood sugar is too high, but it also can be too low. This can happen if you take yourdiabetes medicationsand then skip a meal. Blood sugar also can rise very quickly after a highglycemic indexmeal, and then fall a...
Type 2 diabetes runs in families. Obesity greatly increases the risk of diabetes.Symptoms of type 2 diabetesThe symptoms of diabetes are related to high blood glucose levels. They include:excessive urination, thirst and hunger weight loss increased susceptibility to infections, especially yeast or ...
URINARY tract infectionsTYPE 2 diabetesEFFECTIVE teachingHOSPITAL careBACTERIAL diseasesBackground: Urinary tract infection is the second most commonly seen bacterial infection in the health care sector Each year, more than 8 million people were diagnosed with UTI. According...
if you havetype 1 diabetes, decrease in your insulin dose, serious infection, history of infection of the vagina or penis, history of urinary tract infections, or problems with urination if you areon a low sodium diet, going to have surgery, eating less or change in diet, dehydrated, or ...
Side effects of SGLT-2 inhibitors The most common side effects associated with SGLT-2 inhibitors include: Vaginal yeast infections Yeast infections of the penis Upper respiratory tract infections UTIs Changes in urination (urinary urgency, urinating more often and in larger amounts) Other reported sid...
FARXIGA® (dapagliflozin), a medication for adults with chronic kidney disease (CKD), Heart Failure(HF) and type 2 diabetes (T2D).
Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis: Empagliflozin increases the risk of life-threatening ketoacidosis in patients with type 1 diabetes and fatal ketoacidosis has occurred with empagliflozin. Type 2 diabetes and pancreatic disorders are also risk factors ...
EPIDEMIOLOGY AND INFECTIONVenmans LM;Gorter KJ;Rutten GE;.A clinical predic-tion rule for urinary tract infections in patients with type 2di-abetes mellitus in primary care.Epidemiol Infect.2009.166-172A clinical prediction rule for urinary tract infections in patients with type 2 diabetes mellitus...